Diagnostic yield of 7-day holter ECG monitoring for new AF and association with co-morbidities. Outcomes in an all-comer cohort from a large teaching trust.
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in patients with atrial fibrillation: from asian perspectives
Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?